Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

General

General

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Penny Stocks

Rhythm Shares Climb Following Positive Interim Results From Mid-Stage Obesity Study

By Ragothaman Srinivasan
July 12, 9:42 AM
Rhythm Pharmaceuticals (NASDAQ: RYTM) announced positive interim results from a Phase 2 clinical trial evaluating setmelanotide for the treatment of severe obesity and hyperphagia in people living with hypothalamic obesity.

RYTM

Read More
1 minute read
  • Biotech
  • General

Y-mAbs’ Announces Clearance of IND For GD2-SADA

By Bill Haddad
July 12, 9:15 AM
NEW YORK, July 12, 2022 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the "Company" or "Y-mAbs") (NASDAQ:YMAB) a commercial-stage biopharmaceutical company focused on the development and

YMAB

Read More
1 minute read
  • General
  • News

Peloton Exits In-House Production As Part Of Turnaround

By Shivani Kumaresan
July 12, 9:15 AM
Peloton Interactive Inc (NASDAQ:PTON) said it is exiting all owned-manufacturing operations and expanding its current relationship with leading Taiwanese manufacturer Rexon…

PTON

Read More
3 minute read
  • Biotech
  • FDA
  • General
  • News

Abbott Receives FDA’s Breakthrough Device Designation To Explore Use Of Deep Brain Stimulation To Manage Severe Depression

By Bill Haddad
July 12, 9:09 AM
Breakthrough Device Designations are given by the U.S. FDA to expedite the review of technologies that can improve the lives of people with life-threatening or debilitating conditions Each year, 2.8 million Americans

ABT

Read More
1 minute read
  • General
  • Management
  • News

Dollar General Picks Jeffery Owen To Succeed Todd Vasos As CEO

By Shivani Kumaresan
July 12, 8:53 AM
Dollar General Corp (NYSE:DG) announced Todd Vasos’s decision to retire from his position as Chief Executive Officer (CEO), effective November 1,…

DG

Read More
2 minute read
  • General

Itron, United Systems & Software And Sevier County Utility District To Optimize Natural Gas Operations In Tennessee

By Bill Haddad
July 12, 8:47 AM
Sevier County Utility District to Deploy Itron's Smart Gas Metering Solution to Streamline Meter Reading Itron, Inc. (NASDAQ:ITRI), which is innovating the way utilities and cities manage energy and water, and its

ITRI

Read More
2 minute read
  • General
  • Health Care

ZimVie Announces Anthem Blue Cross Blue Shield Issued Positive Policy Decision Applicable To Anterior Vertebral Body Tethering

By Bill Haddad
July 12, 8:06 AM
ZimVie Inc. (NASDAQ:ZIMV), a global life sciences leader in the dental and spine markets, today announced that Anthem Blue Cross Blue Shield (BCBS), a subsidiary/operating company of Elevance Health, has issued a

ZIMV

Read More
1 minute read
  • General
  • Guidance
  • Management
  • News

Gap CEO Sonia Syngal Steps Down; Company Anticipates Dim Q2 Outlook

By Shivani Kumaresan
July 12, 7:54 AM
Gap Inc (NYSE:GPS) said its president and CEO Sonia Syngal stepped down from her position and the company’s Board, effective immediately.…

GPS

Read More
2 minute read
  • General

Quotient Limited And InfYnity Biomarkers Announce Partnership To Expand MosaiQ Infectious Disease Menu

By Bill Haddad
July 12, 7:37 AM
Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced an agreement with InfYnity Biomarkers, an R&D firm dedicated to utilizing biomarkers for the management of infectious and

QTNT

Read More
1 minute read
  • Earnings
  • General
  • Guidance
  • News

PepsiCo Boosts FY22 Organic Revenue Growth Forecast After Solid Q2 Beat

By Shivani Kumaresan
July 12, 7:14 AM
PepsiCo Inc (NASDAQ:PEP) reported second-quarter FY22 sales growth of 5.2% year-on-year to $20.23 billion, beating the consensus of $19.51 billion. Organic revenue…

PEP

Posts pagination

Previous 1 … 2,339 2,340 2,341 … 2,367 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service